304 related articles for article (PubMed ID: 20049871)
1. Mitogen-activated protein kinase-activated protein kinase 2 (MK2) in skeletal muscle atrophy and hypertrophy.
Norrby M; Tågerud S
J Cell Physiol; 2010 Apr; 223(1):194-201. PubMed ID: 20049871
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase and mitogen-activated protein kinase-activated protein kinase 2 (MK2) signaling in atrophic and hypertrophic denervated mouse skeletal muscle.
Evertsson K; Fjällström AK; Norrby M; Tågerud S
J Mol Signal; 2014 Mar; 9(1):2. PubMed ID: 24629011
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
Hitti E; Iakovleva T; Brook M; Deppenmeier S; Gruber AD; Radzioch D; Clark AR; Blackshear PJ; Kotlyarov A; Gaestel M
Mol Cell Biol; 2006 Mar; 26(6):2399-407. PubMed ID: 16508014
[TBL] [Abstract][Full Text] [Related]
4. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification.
Pallafacchina G; Calabria E; Serrano AL; Kalhovde JM; Schiaffino S
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9213-8. PubMed ID: 12084817
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of a stable MK2-EGFP cell line and subsequent development of a high-content imaging assay on the Cellomics ArrayScan platform to screen for p38 mitogen-activated protein kinase inhibitors.
Williams RG; Kandasamy R; Nickischer D; Trask OJ; Laethem C; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():364-89. PubMed ID: 17110203
[TBL] [Abstract][Full Text] [Related]
6. Changes in signalling molecule levels in 10-day hindlimb immobilized rat muscles.
Machida S; Booth FW
Acta Physiol Scand; 2005 Feb; 183(2):171-9. PubMed ID: 15676058
[TBL] [Abstract][Full Text] [Related]
7. Expression and phosphorylation of eukaryotic translation initiation factor 4-gamma (eIF4G) in denervated atrophic and hypertrophic mouse skeletal muscle.
Fjällström AK; Norrby M; Tågerud S
Cell Biol Int; 2015 Apr; 39(4):496-501. PubMed ID: 25623635
[TBL] [Abstract][Full Text] [Related]
8. A growth stimulus is needed for IGF-1 to induce skeletal muscle hypertrophy in vivo.
Shavlakadze T; Chai J; Maley K; Cozens G; Grounds G; Winn N; Rosenthal N; Grounds MD
J Cell Sci; 2010 Mar; 123(Pt 6):960-71. PubMed ID: 20179101
[TBL] [Abstract][Full Text] [Related]
9. Effect of exercise on activation of the p38 mitogen-activated protein kinase pathway, c-Jun NH2 terminal kinase, and heat shock protein 27 in equine skeletal muscle.
van Ginneken MM; de Graaf-Roelfsema E; Keizer HA; van Dam KG; Wijnberg ID; van der Kolk JH; van Breda E
Am J Vet Res; 2006 May; 67(5):837-44. PubMed ID: 16649919
[TBL] [Abstract][Full Text] [Related]
10. Assay development and case history of a 32K-biased library high-content MK2-EGFP translocation screen to identify p38 mitogen-activated protein kinase inhibitors on the ArrayScan 3.1 imaging platform.
Trask OJ; Baker A; Williams RG; Nickischer D; Kandasamy R; Laethem C; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():419-39. PubMed ID: 17110205
[TBL] [Abstract][Full Text] [Related]
11. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands.
Thuraisingam T; Xu YZ; Moisan J; Lachance C; Garnon J; Di Marco S; Gaestel M; Radzioch D
Mol Immunol; 2007 Jul; 44(14):3482-91. PubMed ID: 17485113
[TBL] [Abstract][Full Text] [Related]
12. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
Rommel C; Bodine SC; Clarke BA; Rossman R; Nunez L; Stitt TN; Yancopoulos GD; Glass DJ
Nat Cell Biol; 2001 Nov; 3(11):1009-13. PubMed ID: 11715022
[TBL] [Abstract][Full Text] [Related]
13. Ca2+/calmodulin-dependent protein kinase kinase-alpha regulates skeletal muscle glucose uptake independent of AMP-activated protein kinase and Akt activation.
Witczak CA; Fujii N; Hirshman MF; Goodyear LJ
Diabetes; 2007 May; 56(5):1403-9. PubMed ID: 17287469
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway.
Shefer G; Oron U; Irintchev A; Wernig A; Halevy O
J Cell Physiol; 2001 Apr; 187(1):73-80. PubMed ID: 11241351
[TBL] [Abstract][Full Text] [Related]
16. Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro.
Hendriks BS; Seidl KM; Chabot JR
BMC Syst Biol; 2010 Mar; 4():23. PubMed ID: 20230629
[TBL] [Abstract][Full Text] [Related]
17. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
18. The adaptive responses in several mediators linked with hypertrophy and atrophy of skeletal muscle after lower limb unloading in humans.
Sakuma K; Watanabe K; Hotta N; Koike T; Ishida K; Katayama K; Akima H
Acta Physiol (Oxf); 2009 Oct; 197(2):151-9. PubMed ID: 19432591
[TBL] [Abstract][Full Text] [Related]
19. Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle.
Magnusson C; Högklint L; Libelius R; Tågerud S
J Neurosci Res; 2001 Nov; 66(3):457-63. PubMed ID: 11746363
[TBL] [Abstract][Full Text] [Related]
20. Reduction of ribosome biogenesis with activation of the mTOR pathway in denervated atrophic muscle.
Machida M; Takeda K; Yokono H; Ikemune S; Taniguchi Y; Kiyosawa H; Takemasa T
J Cell Physiol; 2012 Apr; 227(4):1569-76. PubMed ID: 21678406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
